А. Yu. Efanov

1.1k total citations
24 papers, 196 citations indexed

About

А. Yu. Efanov is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, А. Yu. Efanov has authored 24 papers receiving a total of 196 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 14 papers in Epidemiology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in А. Yu. Efanov's work include Healthcare Systems and Public Health (13 papers), Human Health and Disease (8 papers) and Cardiac Health and Mental Health (5 papers). А. Yu. Efanov is often cited by papers focused on Healthcare Systems and Public Health (13 papers), Human Health and Disease (8 papers) and Cardiac Health and Mental Health (5 papers). А. Yu. Efanov collaborates with scholars based in Russia, United Kingdom and South Korea. А. Yu. Efanov's co-authors include S. А. Shalnova, А. Д. Деев, И. А. Трубачева, Р. А. Либис, С. В. Романчук, S. А. Boytsov, С. В. Недогода, Yu. V. Zhernakova, А. О. Конради and С. Е. Евстифеева and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and European Heart Journal.

In The Last Decade

А. Yu. Efanov

20 papers receiving 159 citations

Peers

А. Yu. Efanov
А. Yu. Efanov
Citations per year, relative to А. Yu. Efanov А. Yu. Efanov (= 1×) peers И. А. Трубачева

Countries citing papers authored by А. Yu. Efanov

Since Specialization
Citations

This map shows the geographic impact of А. Yu. Efanov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by А. Yu. Efanov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites А. Yu. Efanov more than expected).

Fields of papers citing papers by А. Yu. Efanov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by А. Yu. Efanov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by А. Yu. Efanov. The network helps show where А. Yu. Efanov may publish in the future.

Co-authorship network of co-authors of А. Yu. Efanov

This figure shows the co-authorship network connecting the top 25 collaborators of А. Yu. Efanov. A scholar is included among the top collaborators of А. Yu. Efanov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with А. Yu. Efanov. А. Yu. Efanov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Максимов, С. А., S. А. Shalnova, Г. А. Муромцева, et al.. (2023). Physical activity of the Russian population depending on regional housing conditions. (ESSE-RF study). Russian Journal of Preventive Medicine. 26(5). 31–31. 3 indexed citations
3.
Муромцева, Г. А., Е. B. Yarovaya, В. А. Куценко, et al.. (2022). Survival prognosis in individuals with a high spatial QRS-T angle. SHILAP Revista de lepidopterología. 27(9). 5101–5101.
4.
Efanov, А. Yu., et al.. (2019). Pharmacoeconomic effectiveness of using modern technologies in the follow-up care of patients with arterial hypertension. SHILAP Revista de lepidopterología. 38–43.
5.
Shalnova, S. А., М. В. Ежов, V. A. Metelskaya, et al.. (2019). Association Between Lipoprotein(a) and Risk Factors of Atherosclerosis in Russian Population (Data of Observational ESSE-RF study). SHILAP Revista de lepidopterología. 15(5). 612–621. 5 indexed citations
6.
Efanov, А. Yu., et al.. (2018). TREATMENT ADHERENCE AND EFFICACY OF ANTIHYPERTENSION TREATMENT IN HYPERTENSIVES   IN TYUMENSKAYA ObLAST. Russian Journal of Cardiology. 43–48. 4 indexed citations
7.
Kontsevaya, А. V., Katie Bates, Natalia Bobrova, et al.. (2018). Hospital Stage of Myocardial Infarction Treatment in 13 Regions of Russian Federation by Results of the International Research. Rational Pharmacotherapy in Cardiology. 14(4). 474–487. 6 indexed citations
8.
Efanov, А. Yu., et al.. (2017). THE SPECIFICS OF HYPERTENSION PREVALENCE IN TYUMENSKAYA REGION AND ITS TREATMENT EFFICACY AMONG INHABITANTS OF 25-64 YEAR OLD. CARDIOVASCULAR THERAPY AND PREVENTION. 16(1). 27–33. 3 indexed citations
9.
10.
Shalnova, S. А., А. Э. Имаева, А. Д. Деев, et al.. (2017). Elevated Level of the Natriuretic Peptide Among Adult Population in Regions Participating in the ESSE-RF Study and Its Association With Cardiovascular Diseases and Risk Factors. Kardiologiia. 17(12). 43–52. 3 indexed citations
11.
Евстифеева, С. Е., S. А. Shalnova, Yu. I. Grinshtein, et al.. (2017). DIABETES RISK AND ASSOCIATIONS WITH DEMOGRAPHIC AND BEHAVIORAL FACTORS IN RUSSIAN POPULATION: DATA FROM THE ESSE-RF STUDY. Russian Journal of Cardiology. 13–20. 8 indexed citations
12.
Ершова, А. И., А. Н. Мешков, М. А. Сторожок, et al.. (2017). The prevalence of familial hypercholesterolemia in the West Siberian region of the Russian Federation: A substudy of the ESSE-RF. PLoS ONE. 12(7). e0181148–e0181148. 26 indexed citations
13.
Efanov, А. Yu.. (2017). P193Predictors of antihypertensive medical treatment adherence decline. European Heart Journal. 38(suppl_1). 1 indexed citations
14.
Ершова, А. И., А. Н. Мешков, М. А. Сторожок, et al.. (2017). The prevalence of heterozygous familial hypercholesterolemia in the Russian Federation: A substudy of the ESSE-Rf. Atherosclerosis. 263. e184–e185. 1 indexed citations
15.
Скрипникова, И. А., S. А. Shalnova, А. Д. Деев, et al.. (2016). The prevalence of clinical factors used for risk assessment of osteoporotic fractures. Russian Journal of Preventive Medicine. 19(5). 32–32. 11 indexed citations
16.
Евстифеева, С. Е., S. А. Shalnova, А. Д. Деев, et al.. (2016). THE ASSOCIATION OF DEPRESSION WITH C-REACTIVE PROTEIN (THE DATA OF ESSE-RF EPIDEMIOLOGICAL STUDY). Rational Pharmacotherapy in Cardiology. 12(2). 129–137. 1 indexed citations
17.
Евстифеева, С. Е., S. А. Shalnova, А. Д. Деев, et al.. (2015). THE PREVALENCE OF ELEVATED LEVELS OF C-REACTIVE PROTEIN AND ITS ASSOCIATION WITH TRADITIONAL RISK FACTORS AND MORBIDITY AMONG RESIDENTS OF THE RUSSIAN FEDERATION (ACCORDING TO THE ESSE-RF STUDY). SHILAP Revista de lepidopterología. 2 indexed citations
18.
Shalnova, S. А., С. Е. Евстифеева, А. Д. Деев, et al.. (2014). The prevalence of anxiety and depression in different regions of the Russian Federation and its association with sociodemographic factors (according to the data of the ESSE-RF study). Terapevticheskii arkhiv. 86(12). 53–53. 58 indexed citations
19.
Shalnova, S. А., А. Д. Деев, D. V. Duplyakov, et al.. (2014). HYPERURICEMIA AND ITS CORRELATES IN THE RUSSIAN POPULATION (RESULTS OF ESSE-RF EPIDEMIOLOGICAL STUDY). Rational Pharmacotherapy in Cardiology. 10(2). 153–159. 45 indexed citations
20.
Евстифеева, С. Е., Т. М. Гатагонова, А. Yu. Efanov, et al.. (2014). THE PREVALENCE OF ELEVATED LEVELS OF C-REACTIVE PROTEIN AND ITS ASSOCIATION WITH TRADITIONAL RISK FACTORS AND MORBIDITY AMONG RESIDENTS OF THE RUSSIAN FEDERATION (ACCORDING TO THE ESSE-RF STUDY). Rational Pharmacotherapy in Cardiology. 10(6). 597–605. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026